Inflammation and Cancer: Mechanisms, Diagnosis, and Therapeutic Strategies - Tapa blanda

Acerca de los autores

Anoop Kumar is Assistant Professor in the Department of Pharmacology at the Delhi Institute of Pharmaceutical Sciences and Research (DIPSAR), Delhi Pharmaceutical Sciences and Research University (DPSRU), Government of NCT of Delhi, India. He has held academic and research positions in pharmaceutical education, translational research, and the pharmaceutical industry. His professional activities include teaching, research, editorial service, ethics committee responsibilities, and engagement with professional organizations. His research interests include drug repurposing, meta-analysis of clinical trials, network pharmacology, pharmacoeconomics, pharmacovigilance, and experimental pharmacology. He has contributed to scientific publishing and research initiatives that support evidence-based approaches to drug discovery, development, and healthcare decision-making.

Neeraj Mishra is Professor and Head of the Department of Pharmaceutics at the Amity Institute of Pharmacy, Amity University Madhya Pradesh, Gwalior, India. His academic work focuses on novel drug delivery systems, including localized, targeted, and controlled delivery approaches using nanocarrier and microparticle-based technologies. His research interests encompass therapies for cancer and neurodegenerative disorders, and he has extensive experience in teaching, research supervision, and scholarly publishing. He has also contributed to innovation in pharmaceutical sciences through intellectual property development and collaborative academic activities. Through his research and educational initiatives, he supports the advancement of drug delivery strategies and pharmaceutical research.

Arun Kumar Singh is Assistant Professor in the Department of Pharmacy at Vivekanand Global University, India. His teaching and research activities span pharmaceutical sciences and a range of interdisciplinary fields, including nanoformulation, cancer biology, artificial intelligence, machine learning, blockchain technology, the Internet of Things, big data analytics, and neuroscience. He has contributed to scholarly publishing through authorship and editorial work and has participated in research and academic initiatives that integrate emerging technologies with healthcare and pharmaceutical applications. His interests focus on advancing innovative approaches to drug delivery, biomedical research, and technology-enabled solutions for healthcare challenges.

Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences.

Pranav Kumar Prabhakar is Professor and Head of the Department of Biotechnology, School of Engineering and Technology, Nagaland University, Kohima, India. His research focuses on understanding molecular mechanisms involved in metabolic disorders, particularly diabetes, and on developing strategies for oral insulin delivery using natural products and biotechnology-based approaches. He is actively involved in research, academic mentoring, peer review, and editorial activities within the biomedical and biotechnology fields. His professional interests include translational research, signaling pathways associated with metabolic diseases, and the application of biotechnology to improve therapeutic outcomes. He contributes to scientific and academic initiatives that support advancements in biotechnology and healthcare research.